Technology

WHO’s COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP) today finalized a licensing agreement with the Spanish National Research Council (CSIC) for a COVID-19 serological antibody technology. The test effectively checks for the presence of anti-SARS-CoV-2 antibodies developed either in response to a COVID-19 infection or to a vaccine.  This represents the first transparent, global, non-exclusive licence for a COVID-19 health tool, and the first test licence signed by MPP and included in the WHO Pool.The aim of the licence is to facilitate the rapid manufacture and...

You will be able to access:Content tailored to your personal preferences, Favorite content saved within your briefcase, Media advisories, newsletters, and email alerts and PR contact informationEnter your email below and we'll send a link to help you access your account.Try Again.Sorry, your email address is not recognized.An email has been sent.Instructions on how to reset your password have been sent to the email you entered.FORD MEDIA CENTER Mainland China | English Select a locationFord Media CenterPermalinkFord Motor Company today announced plans for a green and modern new Global Technology and...